Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Fidaxomicin”

Showing 9 of 0 results

Large-scale testing (Phase 3)Study completedNCT01691248
What this trial is testing

Safety and Efficacy of Fidaxomicin Versus Placebo for Prophylaxis Against Clostridium Difficile-Associated Diarrhea in Adults Undergoing Hematopoietic Stem Cell Transplantation (MK-5119-001)

Who this might be right for
Clostridium Difficile-Associated Diarrhea (CDAD)
Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) 611
Not applicableStudy completedNCT02461901
What this trial is testing

Does Fidaxomicin Therapy Reduce Spread of Clostridium Difficile?

Who this might be right for
Clostridium Difficile Infection
Professor Mark Wilcox 203
Post-approval studies (Phase 4)Ended earlyNCT02667418
What this trial is testing

Optimal Treatment for Recurrent Clostridium Difficile

Who this might be right for
ClostridiumDifficileFidaxomicin+1 more
VA Office of Research and Development 308
Post-approval studies (Phase 4)WithdrawnNCT02464306
What this trial is testing

Fidaxomicin Versus Standard of Care Therapy in Solid Organ Transplant Recipients With Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionSolid Organ Transplant
University of Colorado, Denver
Not applicableStudy completedNCT02214771
What this trial is testing

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

Who this might be right for
Clostridium Difficile Infection
Astellas Pharma S.A.S. 296
Post-approval studies (Phase 4)Not Yet RecruitingNCT06794944
What this trial is testing

Use of Fidaxomicin Compared to Vancomycin for Decolonization of C. Difficile in Patients With Inflammatory Bowel Disease

Who this might be right for
Inflammatory Bowel Disease (IBD)Clostridioides Difficile Infection
Brigham and Women's Hospital 60
Post-approval studies (Phase 4)Ended earlyNCT01775397
What this trial is testing

A Post-marketing, Blinded Study to Investigate How Effective Fidaxomicin is Compared to Vancomycin in the Sustained Cure of Clostridium Difficile Infection in Adults That Are Receiving Therapy to Suppress the Immune System

Who this might be right for
Clostridium Difficile
Astellas Pharma Europe Ltd. 12
Large-scale testing (Phase 3)Study completedNCT05201079
What this trial is testing

Primary or Recurrent Clostridioides Difficile Infection Treatment With Capsules of Lyophilised Faecal Microbiota vs Fidaxomicin

Who this might be right for
Recurrent Clostridium Difficile InfectionPrimary Clostridium Difficile Infection
Mikrobiomik Healthcare Company S.L. 93
Testing effectiveness (Phase 2)Ended earlyNCT03760484
What this trial is testing

Fecal Microbiota Transplant (FMT) Plus Fidaxomicin for Severe or Fulminant Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile
University of Alberta 4

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation